CLINICAL_TRIALS
trial_result
· 2018-05-15
Clinical Trial Update: A Pilot Study of Pyridostigmine in Pompe Disease [EARLY_Phase 1]
Summary
An early-phase 1 pilot study evaluating pyridostigmine for Pompe disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Pompe Disease | EARLY_Phase 1 | Status: TERMINATED